Which companies overlap with Irmandade da Santa Casa de Misericordia de Sao Paulo's portfolio?

Top competitors by shared drug class: American University of Beirut Medical Center, China International Neuroscience Institution, Derm Research, PLLC, Eye Therapies, LLC, Galderma R&D.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/irmandade-da-santa-casa-de-misericordia-de-sao-paulo.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Irmandade da Santa Casa de Misericordia de Sao Paulo — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Irmandade da Santa Casa de Misericordia de Sao Paulo pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Cimicifuga racemosa	Cimicifuga racemosa	marketed	Copper-containing Intrauterine Device [EPC]
ketamine + clonidine	ketamine + clonidine	phase 3		NMDA receptor, alpha-2 adrenergic receptor	Pain management
clonidine gel 1%	clonidine gel 1%	phase 3	Alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Pain management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

American University of Beirut Medical Center · 1 shared drug class
China International Neuroscience Institution · 1 shared drug class
Derm Research, PLLC · 1 shared drug class
Eye Therapies, LLC · 1 shared drug class
Galderma R&D · 1 shared drug class
Guangzhou Women and Children's Medical Center · 1 shared drug class
Icahn School of Medicine at Mount Sinai · 1 shared drug class
Al-Azhar University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Irmandade da Santa Casa de Misericordia de Sao Paulo:

Cite this brief

Drug Landscape (2026). Irmandade da Santa Casa de Misericordia de Sao Paulo — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/irmandade-da-santa-casa-de-misericordia-de-sao-paulo. Accessed 2026-05-17.